Potential Usage of Afanitib in the Treatment of Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations

被引：0

作者：

Harada, Taishi ^{[1
]}

Yamaba, Yukiko ^{[1
]}

Hayata, Hiroki ^{[1
]}

Okuda, Takashi ^{[2
]}

Kimura, Yoshishige ^{[3
]}

Komaki, Toshiyuki ^{[2
]}

Kagawa, Keizo ^{[2
]}

机构：

[1] Fukuchiyama City Hosp, Med Oncol, Fukuchiyama, Japan

[2] Fukuchiyama City Hosp, Internal Med, Fukuchiyama, Japan

[3] Fukuchiyama City Hosp, Thorac Surg, Fukuchiyama, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

G719X; S768I; afatinib; uncommon EGFR mutation;

D O I：

10.1016/j.jtho.2016.11.1750

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.02b-083

引用

页码：S1241 / S1241

页数：1

共 50 条

[41] BRAF Mutations in Non-Small-Cell Lung Cancer
Smit, Egbert
[J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : 1594 - 1595
[42] Rare mutations in non-small-cell lung cancer
D'Arcangelo, Manolo
D'Incecco, Armida
Cappuzzo, Federico
[J]. FUTURE ONCOLOGY, 2013, 9 (05) : 699 - 711
[43] Comparison of efficacy and safety of second- and third-generation TKIs for non-small-cell lung cancer with uncommon EGFR mutations
Hao, Yue
Xu, Manyi
Jin, Jianan
Si, Jinfei
Xu, Chunwei
Song, Zhengbo
[J]. CANCER MEDICINE, 2023, 12 (15): : 15903 - 15911
[44] Mechanisms of primary resistance to icotinib in Chinese non-small-cell lung cancer patients with EGFR uncommon mutations: A multicenter study.
Wang, Wen Xian
Xu, Chunwei
Zhu, You-Cai
Zhang, Quxia
Chen, Yu
Fang, Yong
Wang, Hong
Zhuang, Wu
Huang, Yun-jian
Fang, Meiyu
Zhang, Yinbin
Wang, Liping
Zhang, Huibao
Zhou, Ying
Zheng, Yu
Hu, Xugang
Jiang, Weiping
Chen, Gang
Lv, Tangfeng
Song, Yong
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[45] Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study
Moran, Teresa
Taus, Alvaro
Arriola, Edurne
Aguado, Carlos
Domine, Manuel
Gomez Rueda, Ana
Calles, Antonio
Cedres, Susana
Vinolas, Nuria
Isla, Dolores
Palmero, Ramon
Sereno, Maria
Diaz, Victor
Juan, Oscar
Marse, Raquel
Martin Martorell, Paloma
Sanchez Torres, Jose Miguel
[J]. CLINICAL LUNG CANCER, 2020, 21 (05) : 428 - +
[46] Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors
Heigener, David F.
Schumann, Christian
Sebastian, Martin
Sadjadian, Parvis
Stehle, Ingo
Maerten, Angela
Lueers, Anne
Griesinger, Frank
Scheffler, Matthias
[J]. ONCOLOGIST, 2015, 20 (10): : 1167 - 1174
[47] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
Yu, Jian
Kane, Susan
Wu, Jiong
Benedettini, Elisa
Li, Daiqiang
Reeves, Cynthia
Innocenti, Gregory
Wetzel, Randy
Crosby, Katherine
Becker, Alison
Ferrante, Michelle
Cheung, Wan Cheung
Hong, Xiqiang
Chirieac, Lucian R.
Sholl, Lynette M.
Haack, Herbert
Smith, Bradley L.
Polakiewicz, Roberto D.
Tan, Yi
Gu, Ting-Lei
Loda, Massimo
Zhou, Xinmin
Comb, Michael J.
[J]. CLINICAL CANCER RESEARCH, 2009, 15 (09) : 3023 - 3028
[48] Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer
Xia, Junbo
Luo, Man
Dai, Lujun
Wang, Liusheng
Wang, Limin
Zhu, Jing
[J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (05)
[49] EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
Wenfeng Fang
Yihua Huang
Shaodong Hong
Zhonghan Zhang
Minghui Wang
Jiadi Gan
Wenjing Wang
Honglin Guo
Kai Wang
Li Zhang
[J]. BMC Cancer, 19
[50] Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis
Paz-Ares, Luis
Soulieres, Denis
Melezinek, Ivan
Moecks, Joachim
Keil, Lorenz
Mok, Tony
Rosell, Rafael
Klughammer, Barbara
[J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (1-2) : 51 - 69

← 1 2 3 4 5 →